These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Phan SH, Kunkel SL. Am J Pathol; 1986 Aug 15; 124(2):343-52. PubMed ID: 2426952 [Abstract] [Full Text] [Related]
35. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Baran CP, Opalek JM, McMaken S, Newland CA, O'Brien JM, Hunter MG, Bringardner BD, Monick MM, Brigstock DR, Stromberg PC, Hunninghake GW, Marsh CB. Am J Respir Crit Care Med; 2007 Jul 01; 176(1):78-89. PubMed ID: 17431224 [Abstract] [Full Text] [Related]
39. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ. J Leukoc Biol; 2006 Jan 01; 79(1):133-9. PubMed ID: 16275889 [Abstract] [Full Text] [Related]
40. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Shimbori C, Shiota N, Okunishi H. Eur J Pharmacol; 2011 Jan 10; 650(1):424-30. PubMed ID: 21034736 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]